Showing Funds Performance since Sep 07, 2020

| Duration | Fund Return(%) | Category Average(%) | Category Best(%) |
|---|---|---|---|
| 1M | 0.00 | 0.49 | 13.06 |
| 6M | 0.00 | 2.13 | 125.97 |
| 1Y | 0.00 | 4.85 | 202.92 |
| 3Y | 0.00 | 13.11 | 342.40 |
Tata Life Sciences and Technology Fund Growth managed by Tata Mutual Fund,is a Equity - Sector Fundscheme with Assets Under Management of ₹43 Crore. The fund benchmarks its performance against the S & P 500 Index (New York) while maintaining an expense ratio of 2.5. Under the expert guidance of Bhupinder Sethi ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.
Mr. Bhupinder holds a B.E. and an MBA from FMS, Delhi. He is associated with Tata Mutual Fund since 2005. Prior to this, he has worked with Jacob Ballas Capital India as Vice President for 2 years, with Dundee Mutual Funds as Fund Manager for 3 years.
| Fund Name | Ratings | AUM | Expense Ratio |
|---|---|---|---|
| Baroda BNP Paribas ESG Best-in-Class Strategy Fund Growth | 0 | 636.38 CR | 2.41 |
| Bajaj Finserv Healthcare Fund Growth | 0 | 332.52 CR | 2.46 |
| Kotak Energy Opportunities Fund Growth | 0 | 270.14 CR | 2.45 |
| HDFC Defence Fund Growth | 5 | 9724.27 CR | 1.75 |
| Nippon India Taiwan Equity Fund Growth | 3 | 1256.27 CR | 2.15 |
| Fund Name | 1Y | 3Y |
|---|---|---|
| This FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund Growth | 0 | 0 |
| This FundBajaj Finserv Healthcare Fund Growth | 11.0102 | 0 |
| This FundKotak Energy Opportunities Fund Growth | 7.473 | 0 |
| This FundHDFC Defence Fund Growth | 14.9064 | 189.4226 |
| This FundNippon India Taiwan Equity Fund Growth | 198.7903 | 324.3981 |